Society | Jun 15

Japan's Daiichi Sankyo halts trials of existing drug for COVID-19 treatment

Jun 15 (Reuters) - Japan's Daiichi Sankyo Co (4568.T) said on Tuesday it was halting development of an existing drug for the treatment of COVID-19.

Daiichi Sankyo in March started a clinical trial in Japan of an inhaled form of nafamostat mesylate with COVID-19 patients. The company said in a statement it was discontinuing the trial without citing a reason. The Nikkei newspaper reported that there were safety concerns.

Nafamostat is used in the treatment of pancreatitis and has antiviral properties.


MORE Society NEWS

As crows enter their breeding season, their nest-building activities are causing concern among utility providers due to the increased risk of power outages.

Japanese company Smile-Up, the former talent agency known as Johnny & Associates, says it has sent a letter of protest to Britain's public broadcaster BBC over its program on sexual abuse by its late founder. (NHK)

Actress Akane Hotta announced on the 26th that she has married a non-celebrity man she had been dating, sharing her joy on Instagram.

POPULAR NEWS

In a significant movement in the foreign exchange markets, the Japanese yen has once again depreciated, crossing the 158 mark against the U.S. dollar. This level marks the weakest the yen has been in approximately 34 years, signaling ongoing economic pressures and potentially major shifts in Japan's financial landscape.

In a remarkable display of bravery and quick thinking, a seven-year-old girl in Kitakyushu successfully rescued her four-year-old sister who had been kidnapped. The incident, which unfolded on April 13th, began when the siblings were approached by a stranger while playing on the street.

Japan's Cabinet Office's Government Public Relations Office recently stirred controversy with a social media post showcasing an overly lavish depiction of school lunches, leading to a public outcry over the authenticity of the meals presented.

Tokyo's Shinagawa district welcomes a new landmark with the grand opening of the Gotanda JP Building on Friday, April 26, featuring a dog-friendly hotel by Hoshino Resort, co-working spaces, and a vibrant culinary scene.

Japanese company Smile-Up, the former talent agency known as Johnny & Associates, says it has sent a letter of protest to Britain's public broadcaster BBC over its program on sexual abuse by its late founder. (NHK)

FOLLOW US